In relation to HCC, AIF1 enhances proliferation of the human hepatoma cell line HepG2 through activation of the insulin growth factor/insulin-like growth factor-1 receptor (IGF/IGF1R) axis and its downstream signaling pathway [131]. Here, IGF1 is linked to hepatocellular carcinoma.